Farmacat SRL
Farmacat reported total assets of €3.67m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
By total assets for 2025, Farmacat ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Farmacat shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +42 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmacat's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 03 Oct 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 18 Jul 2022
Farmacat's financial analysis
- Solvency41.9%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmacat
Farmacat's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0806.801.359
- VAT number
- BE0806801359
- Peppol
- Registered · 0208:0806801359 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Oct 2008
- Registered office
- 8573 Anzegem
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Farmacat (SRL) has been based in Anzegem since 2008, active in: activities of holding companies. For 2025, it reports a net profit of 141,799 € and equity of €1.54m; its revenue is not published. Its solvency stands at 41.9%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmacat
Companies in the same business, of comparable size and area, outside its group.
- Eben Invest Activities of holding companies Beveren-Kruibeke-Zwijndrecht · balance sheet €3.69m
- Holdibor Activities of holding companies Braine-l'Alleud · balance sheet €3.69m
- Milio Activities of holding companies Lummen · balance sheet €4.39m
- Nicolas SIX Holding Activities of holding companies Beloeil · balance sheet €3.64m
- Rik Vandecasteele Activities of holding companies Waasmunster · balance sheet €3.69m
- Edeban Activities of holding companies Kontich · balance sheet €3.63m
- Indeco Activities of holding companies Sint-Niklaas · balance sheet €3.59m
- Tholos Activities of holding companies Wevelgem · balance sheet €3.59m
Frequently asked questions about Farmacat
What is the revenue of Farmacat?
Farmacat files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmacat?
In Belgium, the VAT number is the company number prefixed with BE: BE0806801359 for Farmacat, if the company is VAT-registered. Its company number (CBE) is 0806.801.359.
Where is the registered office of Farmacat?
According to the CBE register, the registered office of Farmacat is in 8573 Anzegem.
What is the equity of Farmacat?
At the close of the 2025 financial year, the equity of Farmacat amounts to 1,537,916 €, a solvency of 41.9% of total assets.
Who manages Farmacat?
The register lists 3 active mandates at Farmacat. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Farmacat within its sector?
By total assets for 2025, Farmacat ranks among the 10,000 largest of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Farmacat
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →